Cohance Lifesciences Limited — Investor Meet, 09-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Suven Pharmaceuticals Limited will host a conference call to discuss its Q3 and 9M FY25 financial results. The management team, including Executive Chairman Mr. Vivek Sharma and key executives, will present the results followed by a Q&A session to address investor inquiries. This call aims to provide insights into the company's financial performance and strategic direction. Interested participants are encouraged to pre-register via the provided link for seamless access to the conference. The call is set for 7.30 PM IST on February 12, 2025.